Unknown Author
January 22, 2026
Kirkland Advises THL Partners on Majority Investment in Red Nucleus

1 min
AI-made summary
- Kirkland & Ellis represented THL Partners in its majority investment in Red Nucleus, a company specializing in strategic services for research and development, medical affairs, market access, and learning and development
- The partnership aims to expand Red Nucleus’ commercialization services for its global clients
- The Kirkland team included lawyers from corporate, tax, technology and IP transactions, and healthcare practices.
Kirkland & Ellis advised THL Partners, a premier private equity firm investing in middle market growth companies, on its majority investment in Red Nucleus, a leading provider of strategic services across research and development, medical affairs, market access and learning and development. The strategic partnership will help broaden Red Nucleus’ suite of commercialization services for its global customer base. Read the transaction press release The Kirkland team included corporate lawyers Kyle McHugh, Josh Dubin, Matt Nelson, Dan O’Dea, Chris Elder and Ted Frankel; tax lawyers Sehj Vather and Chris Worek; technology & IP transactions lawyers Dan Lewis and Matt Darch; and healthcare lawyers Dennis Williams and Kate Hardey.
Article Author
Unknown Author
The Sponsor
